Paired Ends

Premium

Vance Vanier has been appointed as president and CEO of Navigenics. He joined the company as chief medical officer in April of 2008. Prior to that, he was a partner at venture capital firm Mohr Davidow Ventures, where he focused on bringing new genomic technologies into clinical practice. Vanier is also a clinical faculty member of Stanford University Medical Center.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.